[go: up one dir, main page]

MXPA02002452A - Agentes preventivos y terapeuticos para enfermedades de oftalmicas. - Google Patents

Agentes preventivos y terapeuticos para enfermedades de oftalmicas.

Info

Publication number
MXPA02002452A
MXPA02002452A MXPA02002452A MXPA02002452A MXPA02002452A MX PA02002452 A MXPA02002452 A MX PA02002452A MX PA02002452 A MXPA02002452 A MX PA02002452A MX PA02002452 A MXPA02002452 A MX PA02002452A MX PA02002452 A MXPA02002452 A MX PA02002452A
Authority
MX
Mexico
Prior art keywords
eye diseases
preventive
therapeutic agents
hydrates
compound
Prior art date
Application number
MXPA02002452A
Other languages
English (en)
Inventor
Tokushige Hideki
Original Assignee
Ono Pharmaceutical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ono Pharmaceutical Co filed Critical Ono Pharmaceutical Co
Publication of MXPA02002452A publication Critical patent/MXPA02002452A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/235—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/222—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin with compounds having aromatic groups, e.g. dipivefrine, ibopamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Ophthalmology & Optometry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Agentes preventivos y terapeuticos para enfermedades oftalmicas, especialmente enfermedades inflamatorias oftalmicas y ulcera de la cornea, que contienen como ingrediente activo un compuesto representado por la formula (I): (ver formula) sales farmacologicamente aceptables del mismo, o hidratos de ambos.
MXPA02002452A 1999-09-06 2000-09-05 Agentes preventivos y terapeuticos para enfermedades de oftalmicas. MXPA02002452A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP25153899 1999-09-06
PCT/JP2000/006014 WO2001017527A1 (en) 1999-09-06 2000-09-05 Preventive and therapeutic agents for eye diseases

Publications (1)

Publication Number Publication Date
MXPA02002452A true MXPA02002452A (es) 2004-09-10

Family

ID=17224318

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA02002452A MXPA02002452A (es) 1999-09-06 2000-09-05 Agentes preventivos y terapeuticos para enfermedades de oftalmicas.

Country Status (14)

Country Link
US (1) US6624193B1 (es)
EP (1) EP1213018A4 (es)
JP (1) JP4682495B2 (es)
KR (1) KR20020042667A (es)
CN (1) CN1387436A (es)
AU (1) AU6870800A (es)
BR (1) BR0013793A (es)
CA (1) CA2383971A1 (es)
HU (1) HUP0202745A2 (es)
MX (1) MXPA02002452A (es)
NO (1) NO20021094L (es)
NZ (1) NZ517556A (es)
WO (1) WO2001017527A1 (es)
ZA (1) ZA200201819B (es)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6552082B2 (en) * 2000-06-29 2003-04-22 Ono Pharmaceutical Co., Ltd. Solution of N-[o-(p-pivaloyloxybenzenesulfonylamino)benzoyl] glycine monosodium salt tetra-hydrate and drug product thereof
WO2002015878A1 (fr) * 2000-08-25 2002-02-28 Senju Pharmaceutical Co., Ltd. Preparations en suspension aqueuse
US7315848B2 (en) * 2001-12-12 2008-01-01 Aaron Pearse Web snippets capture, storage and retrieval system and method
KR101059711B1 (ko) 2003-01-21 2011-08-29 센주 세이야꾸 가부시키가이샤 2-아미노-3-(4-브로모벤조일)페닐아세트산 함유 수성액제
WO2004064817A1 (ja) * 2003-01-22 2004-08-05 Nichiban Co., Ltd. 眼疾患治療用経皮吸収型製剤、その使用、及び眼疾患治療薬の眼の局所組織への移行方法
US8748402B2 (en) 2004-06-07 2014-06-10 Bausch & Lomb Pharma Holdings Corp. Ophthalmic formulations and uses thereof
US8372814B2 (en) * 2004-06-07 2013-02-12 Ista Pharmaceuticals, Inc. Ophthalmic formulations and uses thereof
US20070208058A1 (en) * 2004-10-25 2007-09-06 Bryant Roy W Stable Pharmaceutical Compositions and Methods of Making and Using Same
US20100160293A1 (en) * 2005-02-17 2010-06-24 Kakuji Tojo Solid Ophthalmic Drug for External Use
EP3210594B1 (en) 2006-09-29 2023-09-13 Johnson & Johnson Vision Care, Inc. Methods and ophthalmic devices used in the treatment of ocular allergies
CA2685230C (en) * 2007-05-04 2012-10-16 Bausch & Lomb Incorporated Compositions for reducing, ameliorating, treating, or preventing condition of dry eye and methods of making and using same
CA2686866A1 (en) * 2007-05-07 2008-11-13 Erning Xia Compositions for reducing, ameliorating, treating, or preventing condition of dry eye and methods of making and using same
US8300252B2 (en) * 2008-06-18 2012-10-30 Livescribe, Inc. Managing objects with varying and repeated printed positioning information
TW201023912A (en) * 2008-12-05 2010-07-01 Alcon Res Ltd Pharmaceutical suspension
JP5583145B2 (ja) * 2009-03-03 2014-09-03 アルコン リサーチ， リミテッド レセプターチロシンキナーゼ阻害（ＲＴＫｉ）化合物の眼への送達のための薬学的組成物
US8912236B2 (en) * 2009-03-03 2014-12-16 Alcon Research, Ltd. Pharmaceutical composition for delivery of receptor tyrosine kinase inhibiting (RTKi) compounds to the eye
TR201901462T4 (tr) 2013-03-14 2019-02-21 Panoptica Inc Gözün posterior segmentine ilaç uygulanması için oküler formülasyonlar.
JP6960399B2 (ja) * 2015-06-16 2021-11-05 ウー・ロン−ツンWU, Rong−Tsun ドライアイを治療または防止する方法
JP2020525416A (ja) * 2017-06-29 2020-08-27 アドヴァイテ エルエルシー． 眼表面障害の治療及び診断

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0320253A (ja) * 1988-06-13 1991-01-29 Ono Pharmaceut Co Ltd ピバル酸　ｐ―置換フェニルエステル誘導体、それらの製造方法およびそれらを有効成分として含有するエラスターゼ阻害剤
US5017610A (en) * 1988-06-13 1991-05-21 Ono Pharmaceutical Co., Ltd. Derivatives of p-substituted phenyl ester of pivalic acid
WO1990004409A1 (en) * 1988-10-27 1990-05-03 University Of Kentucky Research Foundation Human leukocyte elastase inhibitors and methods of producing and using same
ES2111013T3 (es) 1991-06-18 1998-03-01 Fujisawa Pharmaceutical Co Una composicion profilactica/terapeutica que contiene ws7622a para evitar o tratar la coagulacion intravascular diseminada, la enfermedad infecciosa cronica del tracto respiratorio o la bronquitis cronica.
GB9115811D0 (en) 1991-07-22 1991-09-04 Fujisawa Pharmaceutical Co Fr901451 substance,process for preparation thereof and use thereof
CA2081268A1 (en) * 1991-10-25 1993-04-26 Katsuhiro Imaki Glycine derivative monosodium salt tetrahydrate
JPH05194366A (ja) * 1991-10-25 1993-08-03 Ono Pharmaceut Co Ltd グリシン誘導体・モノナトリウム塩・４水和物、その製造方法、それを含有する薬剤および該誘導体の中間体の製造方法

Also Published As

Publication number Publication date
CN1387436A (zh) 2002-12-25
EP1213018A1 (en) 2002-06-12
AU6870800A (en) 2001-04-10
HUP0202745A2 (hu) 2003-01-28
NO20021094L (no) 2002-05-06
KR20020042667A (ko) 2002-06-05
BR0013793A (pt) 2002-05-14
ZA200201819B (en) 2003-05-28
NZ517556A (en) 2003-08-29
JP4682495B2 (ja) 2011-05-11
WO2001017527A9 (fr) 2001-06-21
NO20021094D0 (no) 2002-03-05
WO2001017527A1 (en) 2001-03-15
CA2383971A1 (en) 2001-03-15
US6624193B1 (en) 2003-09-23
EP1213018A4 (en) 2004-04-14

Similar Documents

Publication Publication Date Title
MXPA02002452A (es) Agentes preventivos y terapeuticos para enfermedades de oftalmicas.
TR200200579T2 (tr) Amino-tirazolpiridin türevleri.
NO950297D0 (no) Prolinamidderivater
BG106586A (en) Pyrazolopyramidines as therapeutic agents
TR200000129T2 (tr) Yepyeni spiroazabisiklik heterosiklik bileşikler.
AU2002246728A1 (en) Carboline derivatives
MXPA02003977A (es) Inhibidores de adhesion de celula mediada por al°2.
GB9914486D0 (en) Medicaments
NZ545506A (en) Therapeutic agents useful for treating pain
AU2002249890A1 (en) Carboline derivatives
SE9901573D0 (sv) New compounds
SE9903997D0 (sv) New compounds
MXPA05006889A (es) Compuestos aromaticos como agentes anti-inflamatorios, inmunomoduladores y anti-proliferativos.
GR3025568T3 (en) Medicament for therapeutic and prophylactic treatment of diseases caused by smooth muscle cell hyperplasia.
TW354762B (en) Agent for prophylaxis or treatment of cataract
EP1019047A4 (en) ANTITHROMBOTIC AGENTS
AU2001261707A1 (en) Pirazino '1$m(1)2$m(1) :1, 6! pyrido '3,4-b! indole derivatives
AU2002211493A1 (en) Indole derivatives as pde5-inhibitors
NO983444D0 (no) Benzo(c)kinolizin derivater, deres fremstilling og anvendelse som 5<alfa>-reduktaseinhibitorer
HRP20010885B1 (en) Ethanesulfonyl-piperidine derivatives
SE9901572D0 (sv) New compounds
SE9902387D0 (sv) New pharmaceutically active compounds
ZA981430B (en) Anticancer composition
EP1027051A4 (en) ANTITHROMBOTIC AGENTS
SE9704770D0 (sv) New use